Abstract:Modulators of cardiac cyclic adenosine 3’5’-monophosphate (cAMP) and/or its effector protein kinase A (PKA) are used to treat heart disease. Elucidating the mechanisms of endogenous and pharmacological modulators of cAMP, including phosphodiesterase (PDE) inhibitors, is key to predicating alternative drug therapies for heart failure (HF). PDEs regulate confined cAMP/PKA signaling pathways, depending on PDE isoform and localization. PDE3 regulates the SR and sarcolemmal membrane cAMP pools, controlling calcium influx and efflux at these domains. PDE1 regulates sarcolemmal cAMP/PKA signaling. Despite these differences, inhibitors of either increase heart contractility. However, inhibition of PDE3 is pro-arrhythmic, unlike that of PDE1. The regulation of localized cAMP signaling is key to controlled regulation of cell function, with ramifications for HF, and which GPCR lies upstream of PDE1 remains unknown. We hypothesized that the three cAMP-hydrolyzing cardiac PDEs (1, 3, 4) that are found in the human heart would regulate distinct cAMP signaling pathways. Using the cAMP biosensor EPAC-SH187, we performed fluorescence resonance energy transfer experiments in healthy guinea pig adult ventricular myocytes. Cells were treated with inhibitors of PDEs 1, 3, and 4 along with GPCR agonists isoproterenol, glucagon (gcg), and amthamine (amt), respectively for β-adrenergic, gcg and histamine H2 receptors at sub-maximal doses. Cell function and calcium data were obtained using IonOptix. We first asked if PDEi would synergistically regulate pools of cAMP, and found that PDE4i does at pools of cAMP generated by beta-agonism. PDE3i regulates that generated by amt at the H2R, with comparable effects observed in simultaneous or prior H2R stimulation. The combination of these sub-saturating doses exerted strong inotropic and lusitropic effects in paced myocytes. In neither of these domains, PDE1i changed cAMP levels. However, PDE1i intriguingly attenuated the level of gcg-stimulated cAMP production, suggesting a feedback loop mechanism. We conclude that PDEs 1, 3, and 4 regulate distinct pools of cAMP. Importantly, we demonstrate this in a species where the myocardial expression of these PDEs match that of humans as opposed to smaller rodent models.

286 f 31-Adrenoceptor Stimulation and 32-Adrenoceptor Stimulation Differ in Their Effects on Contraction , Cytosolic Ca 2 + , and Ca 21 Current in Single Rat Ventricular Cells

Single Rat Ventricular Cells

Beta 1-Adrenoceptor Stimulation and Beta 2-Adrenoceptor Stimulation Differ in Their Effects on Contraction, Cytosolic Ca2+, and Ca2+ Current in Single Rat Ventricular Cells.

Beta 2-Adrenergic Receptor-Stimulated Increase in Camp in Rat Heart Cells is Not Coupled to Changes in Ca2+ Dynamics, Contractility, or Phospholamban Phosphorylation.

Receptor Subtype Involved in Α1-Adrenergic Receptor-Mediated Ca2+ Signaling in Cardiomyocytes

The Role of Α_1-Adrenoceptors in Different States of the Cardiac Myocyte

Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding

Different effects of activation of three α1-adrenoceptor subtypes on β-adrenoceptor mediated positive inotropic response in isolated left rat atrial

Alpha(1)-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart

Spontaneous b2-Adrenergic Signaling Fails To Modulate L-Type Ca21 Current in Mouse Ventricular Myocytes

[Effect of Alpha 1-Adrenoceptor Subtypes on Beta-Adrenoceptor Mediated Positive Inotropic Response in Rat Left Atria].

Comparison of the Ca2+ movement by activation of α1-adrenoceptor subtypes in HEK-293 cells

Beta-Adrenoceptors Potentiate Alpha1-Adrenoceptor-mediated Inotropic Response in Rat Left Atria.

Comparison Of The Ca2+ Movement By Activation Of Alpha(1)-Adrenoceptor Subtypes In Hek-293 Cells

Stimulation of Β-Adrenoceptor Subtypes Causes Different Effects in Cardiac Cells

Localized Camp-Dependent Signaling Mediates Beta 2-Adrenergic Modulation of Cardiac Excitation-Contraction Coupling.

Spontaneous beta(2)-adrenergic signaling fails to modulate L-type Ca2+ current in mouse ventricular myocytes

Different Roles Of Alpha(1)-Adrenoceptor Subtypes In Mediating Cardiomyocyte Protein Synthesis In Neonatal Rats

Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation

Abstract Mo139: PDE1, 3 and 4 Inhibition and GPCR Agonism in the Regulation of cAMP Signaling

Intracellular Β 1 -Adrenergic Receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility